Learning Ally Sponsors Nationwide Virtual Screening of Left Behind, a Documentary on the Fight for Dyslexia Equity
Free online access available October 24 – October 31 PRINCETON, N.J, Oct. 29, 2025 /PRNewswire/ -- Learning Ally, a national...
Disability
Santa Barbara City College Partners with Mentavi Health to Deliver Rapid, Clinically Validated ADHD Evaluations for Students
Affordable, clinician-reviewed assessments help SBCC reach accommodation decisions sooner and keep students on track during critical academic periods. GRAND RAPIDS,...
TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in...
Causeway Therapeutics Debuts Positive Data from Phase 2 Clinical Trial of TenoMiR® for Lateral Epicondylitis
Data Show Statistically Significant Improvements in Pain, Function and Tendon Structure in Appropriately Dosed PatientsGLASGOW, Scotland, Oct. 28, 2025 (GLOBE...
ONL Therapeutics Announces Randomization of First Patient in Global Phase 2 GALAXY Trial of Xelafaslatide (ONL1204) in Patients with Geographic Atrophy (GA) Associated with Dry AMD
Approvals received from World Health Organization and United States Adopted Names Council establishing “xelafaslatide” as nonproprietary name for ONL1204 Ophthalmic...
Remedy Robotics and Mission Thrombectomy Announce Partnership to Expand Access to Thrombectomy for Stroke with Telerobotics
Remedy Robotics selected as Mission Thrombectomy's exclusive robotics partner to broaden access to life-saving stroke treatment in the U.S. and...
Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 2025
KYV-101 resulted in a profound reduction in disease-associated autoantibodies and impact on disease activity in patients with difficult-to-treat rheumatoid arthritis...
Novartis showcases significant immunology advancements in ACR congress with new data in complex autoimmune diseases
Late-breaking positive Phase III data from ianalumab NEPTUNUS-1 and NEPTUNUS-2 trials in Sjögren’s disease to be presented Biomarker data informing...
Pets and Mental Health Resource Center Now Available Online
HABRI and Mental Health America Partner to Offer Practical Information for Current and Prospective Pet Owners on the Mental Health...
Oticon announces a revolutionary new hearing aid style: Oticon Zeal™, the world’s most discreet, complete hearing aid
The completely new in-the-ear hearing aid style is the world's first solution where users don't need to compromise between in-the-ear...
Ensora Health releases Future of Therapy report, revealing therapists’ current views and predictions for mental healthcare in 2030
Insights from 1,300+ therapists highlight the trends, challenges, and innovations shaping the next era of care. BOSTON, Oct. 21, 2025...
ManagingLife Unveils Solace, the First AI Companion Providing Evidence-Based Pain Psychology Support
TORONTO, Oct. 20, 2025 /PRNewswire/ -- ManagingLife, creators of the Manage My Pain platform, today announced the launch of Solace,...
Nabsys Presents Novel Disease Insights and Advantages in Structural Variant Detection using OhmX™ Platform at American Society of Human Genetics (ASHG) 2025 Annual Meeting
Multi-omics study utilizing electronic genome mapping (EGM) reveals 70% of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) have psychiatric comorbidities...
National PKU Alliance Grant Advances Engineered Native Bacteria Candidate for Phenylketonuria (PKU)
San Diego, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Endure Biotherapeutics, Inc. (Endure Bio®), a pioneer in engineered engraftable microbial therapeutics,...
Bristol Myers Squibb Foundation Announces $1 Million Donation to Patient Advocate Foundation
New contribution will help expand access to care by strengthening the Patient Advocate Foundation's capacity to deliver essential services and...
Tr1X Announces FDA Clearance of IND Application for TRX319, a First-in-Class Allogeneic CAR-Tr1 Treg Cell Therapy for Progressive Multiple Sclerosis, and $50 Million in Additional Financing
On track to initiate TRX319 Phase 1/2a dose-escalation trial in early 2026 TRX319 is an allogeneic CAR-Tr1 Treg cell therapy...
Remedy Robotics and the Australian Stroke Alliance Enter Strategic Partnership to Bring Endovascular Care to Hospitals Across Australia
Remedy Robotics has been selected by the Australian Stroke Alliance as its exclusive robotics partner to expand access to endovascular thrombectomy,...
Foundation Fighting Blindness Marks World Mental Health Day with Upcoming Webinar for Eye Care Professionals: Seeing Beyond Vision Loss – A Focus on Mental Health Resources for Patients with Retinal Disease
The free, online event at 7 p.m. ET on Tuesday, November 11, 2025, will feature presentations from patient advocate Jessie...
Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
– An analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed continuing improvements in...
Health Systems Simplify Secure Data Exchange with Oracle Health
New Oracle Health Connection Hub delivers single, unified console to enable data sharing control, auditing, and governance so health systems...